{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.03 vs. cons $2.00",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.95B vs. cons $1.94B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core operating margin",
      "prediction": "BEAT",
      "answer": "pred ~31.8% vs. cons 31.4%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$8.06 vs. cons $8.10 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "3Q26 adjusted EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$2.06 vs. cons $2.09 (3Q26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 organic sales growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~5.0% vs. cons 5.0% (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.2,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest quarterly EPS and margin beat is likely outweighed by FY26 EPS guidance of ~$8.06 versus ~$8.10 consensus and 3Q26 EPS guidance of ~$2.06 versus ~$2.09 consensus; the implied out-period shortfall should drive estimate cuts despite unchanged ~5.0% FY26 organic-growth guidance.",
  "day5_confidence": "MEDIUM"
}